Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE
HealthData.Gov
Updated Oct 29, 2026
About this dataset
The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix.
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE on the official website.
Modified Apr 29, 2026